Effects of Different Colors of Light on Human Physiology
NCT ID: NCT00200863
Last Updated: 2014-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
47 participants
INTERVENTIONAL
2005-04-30
2007-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Light Sensitization Study
NCT01327040
The Circadian Rhythm of ICU Patients With Acute Myocardial Infraction and the Effect of Light Therapy
NCT04953767
Effect of Bright Light Treatment On Elders In a Long Term Care Environment
NCT01042587
A Study on the Changes of the Biological Rhythm by Display Image Modulation
NCT02690311
The Effect of Bright Light Therapy on Migraine With Sleep Disturbance
NCT04890691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We will test the hypotheses that: 1) light-induced activation of the neurobiological sleep-wake regulatory system, as indicated by increased alertness, faster reaction time, suppression of EEG alpha activity, microsleeps and slow rolling eye movements, and suppression of pineal melatonin, is most sensitive to retinal exposure to short wavelength blue light (460 nm) compared to equal photons of other colors of visible light; 2) light-induced activation of autonomic and hypothalamic-pituitary-adrenal axis measures of arousal, as indicated by increased heart rate variability, core body temperature, blood pressure, respiration rate, plasma cortisol levels and urinary catecholamines, is most sensitive to exposure to short wavelength blue light (460 nm) compared to equal photons of other colors; 3) phase shifts of the human circadian pacemaker, as assessed by changes in temperature, melatonin and cortisol rhythms, are most sensitive to exposure to short wavelength blue light (460 nm) compared to equal photons of other colors. The resultant action spectra will help to identify the photoreceptor mechanism(s) by which light activates arousal and circadian resetting, these non-image-forming physiological responses and enable us to distinguish between major candidate photoreceptive mechanisms, including potential novel photoreceptor systems, that might mediate such responses.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
420 nm light
Monochromatic visible light exposure
Monochromatic light in the visible range from 420-620 nm up to 60uW/cm2 for 6.5 hours
2
480 nm
Monochromatic visible light exposure
Monochromatic light in the visible range from 420-620 nm up to 60uW/cm2 for 6.5 hours
3
507 nm
Monochromatic visible light exposure
Monochromatic light in the visible range from 420-620 nm up to 60uW/cm2 for 6.5 hours
4
555 nm
Monochromatic visible light exposure
Monochromatic light in the visible range from 420-620 nm up to 60uW/cm2 for 6.5 hours
5
620 nm
Monochromatic visible light exposure
Monochromatic light in the visible range from 420-620 nm up to 60uW/cm2 for 6.5 hours
6
460 nm
Monochromatic visible light exposure
Monochromatic light in the visible range from 420-620 nm up to 60uW/cm2 for 6.5 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Monochromatic visible light exposure
Monochromatic light in the visible range from 420-620 nm up to 60uW/cm2 for 6.5 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Drug-free (including caffeine, nicotine, and alcohol) for entire study duration
Exclusion Criteria
* History of psychiatric illnesses or evidence of psychopathology according to standardized questionnaires, or in a structured clinical interview
* Night shift work during the past 3 years
* Transmeridian travel in the last 3 months
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Complementary and Integrative Health (NCCIH)
NIH
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steven W. Lockley
Neuroscientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven W Lockley, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital, Harvard Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Sleep Medicine, Brigham and Women's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gooley JJ, Chamberlain K, Smith KA, Khalsa SB, Rajaratnam SM, Van Reen E, Zeitzer JM, Czeisler CA, Lockley SW. Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab. 2011 Mar;96(3):E463-72. doi: 10.1210/jc.2010-2098. Epub 2010 Dec 30.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.